메뉴 건너뛰기




Volumn 13, Issue 6, 2012, Pages 568-569

Personalised medicine in nasopharyngeal cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VIRUS DNA; WNT PROTEIN;

EID: 84861577316     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70115-8     Document Type: Letter
Times cited : (4)

References (7)
  • 1
    • 79955816514 scopus 로고    scopus 로고
    • Relationship between traditional Chinese medicine syndrome differentiation and imaging characterization to the radiosensitivity of nasopharyngeal carcinoma
    • Bao H, Gao J, Huang T, Zhou ZM, Zhang B, Xia YF Relationship between traditional Chinese medicine syndrome differentiation and imaging characterization to the radiosensitivity of nasopharyngeal carcinoma. Chin J Cancer 2010, 29:937-945.
    • (2010) Chin J Cancer , vol.29 , pp. 937-945
    • Bao, H.1    Gao, J.2    Huang, T.3    Zhou, Z.M.4    Zhang, B.5    Xia, Y.F.6
  • 2
    • 34047181109 scopus 로고    scopus 로고
    • HLA class II polymorphisms associated with the physiologic characteristics defined by traditional Chinese medicine: linking modern genetics with an ancient medicine
    • Chen S, Lv F, Gao J, et al. HLA class II polymorphisms associated with the physiologic characteristics defined by traditional Chinese medicine: linking modern genetics with an ancient medicine. J Altern Complement Med 2007, 13:231-239.
    • (2007) J Altern Complement Med , vol.13 , pp. 231-239
    • Chen, S.1    Lv, F.2    Gao, J.3
  • 3
    • 83355163401 scopus 로고    scopus 로고
    • Eight-signature classifier for prediction of nasopharyngeal carcinoma survival
    • Wang HY, Sun BY, Zhu ZH, et al. Eight-signature classifier for prediction of nasopharyngeal carcinoma survival. J Clin Oncol 2011, 29:4516-4525.
    • (2011) J Clin Oncol , vol.29 , pp. 4516-4525
    • Wang, H.Y.1    Sun, B.Y.2    Zhu, Z.H.3
  • 4
    • 84861572492 scopus 로고    scopus 로고
    • Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
    • published online May 3.
    • Liu N, Chen NY, Cui RX, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 2012, published online May 3. 10.1016/S1470-2045(12)70102-X.
    • (2012) Lancet Oncol
    • Liu, N.1    Chen, N.Y.2    Cui, R.X.3
  • 5
    • 84856211556 scopus 로고    scopus 로고
    • Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs
    • Gourzones C, Jimenez AS, Busson P Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012, 118:698-710.
    • (2012) Cancer , vol.118 , pp. 698-710
    • Gourzones, C.1    Jimenez, A.S.2    Busson, P.3
  • 6
    • 20644435370 scopus 로고    scopus 로고
    • Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
    • Chan AT, Hsu MM, Goh BC, et al. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 2005, 23:3568-3576.
    • (2005) J Clin Oncol , vol.23 , pp. 3568-3576
    • Chan, A.T.1    Hsu, M.M.2    Goh, B.C.3
  • 7
    • 80051676486 scopus 로고    scopus 로고
    • A phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma
    • Lim WT, Ng QS, Ivy P, et al. A phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma. Clin Cancer Res 2011, 17:5481-5489.
    • (2011) Clin Cancer Res , vol.17 , pp. 5481-5489
    • Lim, W.T.1    Ng, Q.S.2    Ivy, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.